These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 25881502)

  • 1. A Phosphorylation-Induced Turn Defines the Alzheimer's Disease AT8 Antibody Epitope on the Tau Protein.
    Gandhi NS; Landrieu I; Byrne C; Kukic P; Amniai L; Cantrelle FX; Wieruszeski JM; Mancera RL; Jacquot Y; Lippens G
    Angew Chem Int Ed Engl; 2015 Jun; 54(23):6819-23. PubMed ID: 25881502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epitope mapping of mAbs AT8 and Tau5 directed against hyperphosphorylated regions of the human tau protein.
    Porzig R; Singer D; Hoffmann R
    Biochem Biophys Res Commun; 2007 Jun; 358(2):644-9. PubMed ID: 17499212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epitope mapping and structural basis for the recognition of phosphorylated tau by the anti-tau antibody AT8.
    Malia TJ; Teplyakov A; Ernst R; Wu SJ; Lacy ER; Liu X; Vandermeeren M; Mercken M; Luo J; Sweet RW; Gilliland GL
    Proteins; 2016 Apr; 84(4):427-34. PubMed ID: 26800003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recognition of the minimal epitope of monoclonal antibody Tau-1 depends upon the presence of a phosphate group but not its location.
    Szendrei GI; Lee VM; Otvos L
    J Neurosci Res; 1993 Feb; 34(2):243-9. PubMed ID: 7680727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the AT180 epitope of phosphorylated Tau protein by a combined nuclear magnetic resonance and fluorescence spectroscopy approach.
    Amniai L; Lippens G; Landrieu I
    Biochem Biophys Res Commun; 2011 Sep; 412(4):743-6. PubMed ID: 21871442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sequential phosphorylation of Tau by glycogen synthase kinase-3beta and protein kinase A at Thr212 and Ser214 generates the Alzheimer-specific epitope of antibody AT100 and requires a paired-helical-filament-like conformation.
    Zheng-Fischhöfer Q; Biernat J; Mandelkow EM; Illenberger S; Godemann R; Mandelkow E
    Eur J Biochem; 1998 Mar; 252(3):542-52. PubMed ID: 9546672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epitope mapping of monoclonal antibodies to the paired helical filaments of Alzheimer's disease: identification of phosphorylation sites in tau protein.
    Goedert M; Jakes R; Crowther RA; Cohen P; Vanmechelen E; Vandermeeren M; Cras P
    Biochem J; 1994 Aug; 301 ( Pt 3)(Pt 3):871-7. PubMed ID: 7519852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tau Antibody Structure Reveals a Molecular Switch Defining a Pathological Conformation of the Tau Protein.
    Chukwu JE; Pedersen JT; Pedersen LØ; Volbracht C; Sigurdsson EM; Kong XP
    Sci Rep; 2018 Apr; 8(1):6209. PubMed ID: 29670132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DC11: a novel monoclonal antibody revealing Alzheimer's disease-specific tau epitope.
    Vechterova L; Kontsekova E; Zilka N; Ferencik M; Ravid R; Novak M
    Neuroreport; 2003 Jan; 14(1):87-91. PubMed ID: 12544837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Site-specific regulation of Alzheimer-like tau phosphorylation in living neurons.
    Burack MA; Halpain S
    Neuroscience; 1996 May; 72(1):167-84. PubMed ID: 8730715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunological memory to hyperphosphorylated tau in asymptomatic individuals.
    Pascual G; Wadia JS; Zhu X; Keogh E; Kükrer B; van Ameijde J; Inganäs H; Siregar B; Perdok G; Diefenbach O; Nahar T; Sprengers I; Koldijk MH; der Linden EC; Peferoen LA; Zhang H; Yu W; Li X; Wagner M; Moreno V; Kim J; Costa M; West K; Fulton Z; Chammas L; Luckashenak N; Fletcher L; Holland T; Arnold C; Anthony Williamson R; Hoozemans JJ; Apetri A; Bard F; Wilson IA; Koudstaal W; Goudsmit J
    Acta Neuropathol; 2017 May; 133(5):767-783. PubMed ID: 28341999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of Alzheimer-specific Tau epitope AT100 in apoptotic human fetal astrocytes.
    Ksiezak-Reding H; He D; Gordon-Krajcer W; Kress Y; Lee S; Dickson DW
    Cell Motil Cytoskeleton; 2000 Nov; 47(3):236-52. PubMed ID: 11056524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation and characterization of new monoclonal antibodies targeting the PHF1 and AT8 epitopes on human tau.
    Strang KH; Goodwin MS; Riffe C; Moore BD; Chakrabarty P; Levites Y; Golde TE; Giasson BI
    Acta Neuropathol Commun; 2017 Jul; 5(1):58. PubMed ID: 28760159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early phosphorylation of tau in Alzheimer's disease occurs at Ser-202 and is preferentially located within neurites.
    Su JH; Cummings BJ; Cotman CW
    Neuroreport; 1994 Nov; 5(17):2358-62. PubMed ID: 7533559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proline-directed pseudo-phosphorylation at AT8 and PHF1 epitopes induces a compaction of the paperclip folding of Tau and generates a pathological (MC-1) conformation.
    Jeganathan S; Hascher A; Chinnathambi S; Biernat J; Mandelkow EM; Mandelkow E
    J Biol Chem; 2008 Nov; 283(46):32066-76. PubMed ID: 18725412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pattern of human tau phosphorylation is the result of priming and feedback events in primary hippocampal neurons.
    Bertrand J; Plouffe V; Sénéchal P; Leclerc N
    Neuroscience; 2010 Jun; 168(2):323-34. PubMed ID: 20394726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural impact of proline-directed pseudophosphorylation at AT8, AT100, and PHF1 epitopes on 441-residue tau.
    Bibow S; Ozenne V; Biernat J; Blackledge M; Mandelkow E; Zweckstetter M
    J Am Chem Soc; 2011 Oct; 133(40):15842-5. PubMed ID: 21910444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complementary distribution of tau proteins in different phosphorylation states within growing axons.
    Rebhan M; Vacun G; Rösner H
    Neuroreport; 1995 Feb; 6(3):429-32. PubMed ID: 7766837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epitope determines efficacy of therapeutic anti-Tau antibodies in a functional assay with human Alzheimer Tau.
    Courade JP; Angers R; Mairet-Coello G; Pacico N; Tyson K; Lightwood D; Munro R; McMillan D; Griffin R; Baker T; Starkie D; Nan R; Westwood M; Mushikiwabo ML; Jung S; Odede G; Sweeney B; Popplewell A; Burgess G; Downey P; Citron M
    Acta Neuropathol; 2018 Nov; 136(5):729-745. PubMed ID: 30238240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual effects of PKNalpha and protein kinase C on phosphorylation of tau protein by glycogen synthase kinase-3beta.
    Isagawa T; Mukai H; Oishi K; Taniguchi T; Hasegawa H; Kawamata T; Tanaka C; Ono Y
    Biochem Biophys Res Commun; 2000 Jun; 273(1):209-12. PubMed ID: 10873588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.